+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Gabapentin Market Segmentation:
Gabapentin Dosage Form Outlook (USD Billion, 2018-2032)
· Tablet
· Capsule
· Oral Solution
Gabapentin Type Outlook (USD Billion, 2018-2032)
· Generic
· Branded
Gabapentin Application Outlook (USD Billion, 2018-2032)
· Epilepsy
· Neuropathic Pain
· Restless Legs Syndrome
· Others
Gabapentin Distribution Channel Outlook (USD Billion, 2018-2032)
· Hospital Pharmacy
· Retail Pharmacy
· Online Pharmacy
· Others
Gabapentin Regional Outlook (USD Billion, 2018-2032)
· North America Outlook (USD Billion, 2018-2032)
o Gabapentin by Dosage Form
§ Tablet
§ Capsule
§ Oral Solution
o Gabapentin by Type
§ Generic
§ Branded
o Gabapentin by Application
§ Epilepsy
§ Neuropathic Pain
§ Restless Legs Syndrome
§ Others
o Gabapentin by Distribution Channel
§ Hospital Pharmacy
§ Retail Pharmacy
§ Online Pharmacy
§ Others
o US Outlook (USD Billion, 2018-2032)
o Gabapentin by Dosage Form
§ Tablet
§ Capsule
§ Oral Solution
o Gabapentin by Type
§ Generic
§ Branded
o Gabapentin by Application
§ Epilepsy
§ Neuropathic Pain
§ Restless Legs Syndrome
§ Others
o Gabapentin by Distribution Channel
§ Hospital Pharmacy
§ Retail Pharmacy
§ Online Pharmacy
§ Others
o Canada Outlook (USD Billion, 2018-2032)
o Gabapentin by Dosage Form
§ Tablet
§ Capsule
§ Oral Solution
o Gabapentin by Type
§ Generic
§ Branded
o Gabapentin by Application
§ Epilepsy
§ Neuropathic Pain
§ Restless Legs Syndrome
§ Others
o Gabapentin by Distribution Channel
§ Hospital Pharmacy
§ Retail Pharmacy
§ Online Pharmacy
§ Others
· Europe Outlook (USD Billion, 2018-2032)
o Gabapentin by Dosage Form
§ Tablet
§ Capsule
§ Oral Solution
o Gabapentin by Type
§ Generic
§ Branded
o Gabapentin by Application
§ Epilepsy
§ Neuropathic Pain
§ Restless Legs Syndrome
§ Others
o Gabapentin by Distribution Channel
§ Hospital Pharmacy
§ Retail Pharmacy
§ Online Pharmacy
§ Others
o Germany Outlook (USD Billion, 2018-2032)
o Gabapentin by Dosage Form
§ Tablet
§ Capsule
§ Oral Solution
o Gabapentin by Type
§ Generic
§ Branded
o Gabapentin by Application
§ Epilepsy
§ Neuropathic Pain
§ Restless Legs Syndrome
§ Others
o Gabapentin by Distribution Channel
§ Hospital Pharmacy
§ Retail Pharmacy
§ Online Pharmacy
§ Others
o France Outlook (USD Billion, 2018-2032)
o Gabapentin by Dosage Form
§ Tablet
§ Capsule
§ Oral Solution
o Gabapentin by Type
§ Generic
§ Branded
o Gabapentin by Application
§ Epilepsy
§ Neuropathic Pain
§ Restless Legs Syndrome
§ Others
o Gabapentin by Distribution Channel
§ Hospital Pharmacy
§ Retail Pharmacy
§ Online Pharmacy
§ Others
o UK Outlook (USD Billion, 2018-2032)
o Gabapentin by Dosage Form
§ Tablet
§ Capsule
§ Oral Solution
o Gabapentin by Type
§ Generic
§ Branded
o Gabapentin by Application
§ Epilepsy
§ Neuropathic Pain
§ Restless Legs Syndrome
§ Others
o Gabapentin by Distribution Channel
§ Hospital Pharmacy
§ Retail Pharmacy
§ Online Pharmacy
§ Others
o Italy Outlook (USD Billion, 2018-2032)
o Gabapentin by Dosage Form
§ Tablet
§ Capsule
§ Oral Solution
o Gabapentin by Type
§ Generic
§ Branded
o Gabapentin by Application
§ Epilepsy
§ Neuropathic Pain
§ Restless Legs Syndrome
§ Others
o Gabapentin by Distribution Channel
§ Hospital Pharmacy
§ Retail Pharmacy
§ Online Pharmacy
§ Others
o Spain Outlook (USD Billion, 2018-2032)
o Gabapentin by Dosage Form
§ Tablet
§ Capsule
§ Oral Solution
o Gabapentin by Type
§ Generic
§ Branded
o Gabapentin by Application
§ Epilepsy
§ Neuropathic Pain
§ Restless Legs Syndrome
§ Others
o Gabapentin by Distribution Channel
§ Hospital Pharmacy
§ Retail Pharmacy
§ Online Pharmacy
§ Others
o Rest Of Europe Outlook (USD Billion, 2018-2032)
o Gabapentin by Dosage Form
§ Tablet
§ Capsule
§ Oral Solution
o Gabapentin by Type
§ Generic
§ Branded
o Gabapentin by Application
§ Epilepsy
§ Neuropathic Pain
§ Restless Legs Syndrome
§ Others
o Gabapentin by Distribution Channel
§ Hospital Pharmacy
§ Retail Pharmacy
§ Online Pharmacy
§ Others
· Asia-Pacific Outlook (USD Billion, 2018-2032)
o Gabapentin by Dosage Form
§ Tablet
§ Capsule
§ Oral Solution
o Gabapentin by Type
§ Generic
§ Branded
o Gabapentin by Application
§ Epilepsy
§ Neuropathic Pain
§ Restless Legs Syndrome
§ Others
o Gabapentin by Distribution Channel
§ Hospital Pharmacy
§ Retail Pharmacy
§ Online Pharmacy
§ Others
o China Outlook (USD Billion, 2018-2032)
o Gabapentin by Dosage Form
§ Tablet
§ Capsule
§ Oral Solution
o Gabapentin by Type
§ Generic
§ Branded
o Gabapentin by Application
§ Epilepsy
§ Neuropathic Pain
§ Restless Legs Syndrome
§ Others
o Gabapentin by Distribution Channel
§ Hospital Pharmacy
§ Retail Pharmacy
§ Online Pharmacy
§ Others
o Japan Outlook (USD Billion, 2018-2032)
o Gabapentin by Dosage Form
§ Tablet
§ Capsule
§ Oral Solution
o Gabapentin by Type
§ Generic
§ Branded
o Gabapentin by Application
§ Epilepsy
§ Neuropathic Pain
§ Restless Legs Syndrome
§ Others
o Gabapentin by Distribution Channel
§ Hospital Pharmacy
§ Retail Pharmacy
§ Online Pharmacy
§ Others
o India Outlook (USD Billion, 2018-2032)
o Gabapentin by Dosage Form
§ Tablet
§ Capsule
§ Oral Solution
o Gabapentin by Type
§ Generic
§ Branded
o Gabapentin by Application
§ Epilepsy
§ Neuropathic Pain
§ Restless Legs Syndrome
§ Others
o Gabapentin by Distribution Channel
§ Hospital Pharmacy
§ Retail Pharmacy
§ Online Pharmacy
§ Others
o Australia Outlook (USD Billion, 2018-2032)
o Gabapentin by Dosage Form
§ Tablet
§ Capsule
§ Oral Solution
o Gabapentin by Type
§ Generic
§ Branded
o Gabapentin by Application
§ Epilepsy
§ Neuropathic Pain
§ Restless Legs Syndrome
§ Others
o Gabapentin by Distribution Channel
§ Hospital Pharmacy
§ Retail Pharmacy
§ Online Pharmacy
§ Others
o Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)
o Gabapentin by Dosage Form
§ Tablet
§ Capsule
§ Oral Solution
o Gabapentin by Type
§ Generic
§ Branded
o Gabapentin by Application
§ Epilepsy
§ Neuropathic Pain
§ Restless Legs Syndrome
§ Others
o Gabapentin by Distribution Channel
§ Hospital Pharmacy
§ Retail Pharmacy
§ Online Pharmacy
§ Others
· Rest of the World Outlook (USD Billion, 2018-2032)
o Gabapentin by Dosage Form
§ Tablet
§ Capsule
§ Oral Solution
o Gabapentin by Type
§ Generic
§ Branded
o Gabapentin by Application
§ Epilepsy
§ Neuropathic Pain
§ Restless Legs Syndrome
§ Others
o Gabapentin by Distribution Channel
§ Hospital Pharmacy
§ Retail Pharmacy
§ Online Pharmacy
§ Others
o Middle East Outlook (USD Billion, 2018-2032)
o Gabapentin by Dosage Form
§ Tablet
§ Capsule
§ Oral Solution
o Gabapentin by Type
§ Generic
§ Branded
o Gabapentin by Application
§ Epilepsy
§ Neuropathic Pain
§ Restless Legs Syndrome
§ Others
o Gabapentin by Distribution Channel
§ Hospital Pharmacy
§ Retail Pharmacy
§ Online Pharmacy
§ Others
o Africa Outlook (USD Billion, 2018-2032)
o Gabapentin by Dosage Form
§ Tablet
§ Capsule
§ Oral Solution
o Gabapentin by Type
§ Generic
§ Branded
o Gabapentin by Application
§ Epilepsy
§ Neuropathic Pain
§ Restless Legs Syndrome
§ Others
o Gabapentin by Distribution Channel
§ Hospital Pharmacy
§ Retail Pharmacy
§ Online Pharmacy
§ Others
o Latin America Outlook (USD Billion, 2018-2032)
o Gabapentin by Dosage Form
§ Tablet
§ Capsule
§ Oral Solution
o Gabapentin by Type
§ Generic
§ Branded
o Gabapentin by Application
§ Epilepsy
§ Neuropathic Pain
§ Restless Legs Syndrome
§ Others
o Gabapentin by Distribution Channel
§ Hospital Pharmacy
§ Retail Pharmacy
§ Online Pharmacy
§ Others
Report Code :
RL65112
Published on :
Aug 2023
Request a Free Sample Report
Speak to Analyst